# Proxima Ventures

> Proxima Ventures is a VC fund backing Medical, Health Care and Biotechnology. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 4
- Last investment: May 2023
- Lead investor: 100%
- Last updated: Aug 2026
- Website: https://www.proximavc.com/

Proxima Ventures is a VC fund focused on Medical and Health Care. Proxima Ventures is building, investing, and growing the next-generation healthcare companies.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 3 | 75% |
| Health Care | 2 | 50% |
| Biotechnology | 2 | 50% |
| Medical Device | 2 | 50% |
| Genetics | 1 | 25% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 25% |
| Angel | 1 | 25% |
| Series A | 1 | 25% |
| Series B | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Mingzhun Medical | Mingzhun Medical is an innovative medical devices company that aims first clinical application of cutting-edge optical microscopic imaging technology. | $1.4M | Angel | May 27, 2023 |  |
| Daxiang Biotech | Daxiang Biotech develops and produces human organoid chips. It is committed to promoting organoid chips in new drug research and development, disease modeling, and individualization. | $12.7M | Series B | Nov 14, 2022 |  |
| ViewGene | ViewGene is a gene therapy company that has developed a proprietary inducible and tissue-specific gene therapy platform in China. The platform reduces the potential risks of uncontrollable dose and overexpression of gene expression and overcomes the shortcomings of traditional gene therapy techniques such as tissue destruction, immunogenicity,inflammatory response, and short onset time in vivo. The highlights of its gene therapy drugs are the clear dose-response relationship and high safety, which have significant advantages in the treatment of single-gene genetic diseases. |  | Seed | Sep 19, 2022 |  |
| Leadinno Medical Valley | Leadino Medical Valley is a producer of medical devices for neuroregulatory functions. | $14.4M | Series A | Sep 09, 2022 |  |

4 of 4 investments shown.

## Co-investors
- [Prox Ventures](https://shizune.co/investors/profile/prox-ventures) — VC Fund, 5 deals together
- [Med-Fine Capital](https://shizune.co/investors/profile/med-fine-capital) — VC Fund, 2 deals together
- [Meihong Investment](https://shizune.co/investors/profile/meihong-investment) — VC Fund, 1 deal together
- [Power Fang Health Fund](https://shizune.co/investors/profile/power-fang-health-fund) — VC Fund, 1 deal together
- [Shaanxi Investment Capital](https://shizune.co/investors/profile/shaanxi-investment-capital) — VC Fund, 1 deal together
- [Taiyu Investment](https://shizune.co/investors/profile/taiyu-investment) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Life Science Investors in China](https://shizune.co/investors/life-science-investors-china)
- [Life Science VC Funds in China](https://shizune.co/investors/life-science-vc-funds-china)
- [Life Science VC Funds in Asia](https://shizune.co/investors/life-science-vc-funds-asia)

## FAQ

### What does Proxima Ventures invest in?

Proxima Ventures invests primarily in Medical, Health Care and Biotechnology startups, most often at Seed and Angel stage. Most of the 4 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Proxima Ventures last invest?

The most recent investment recorded for Proxima Ventures closed in May 2023. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co